Skip to main content
High RiskFDAfda-F-3611-2017UNDECLARED ALLERGEN

Coborn's/Cash Wise Caraway Rye Bread - UPC 7-33147-20155-8 Net Wt. 16 oz (1.0 lb) (454 g) Sell by 9/6/2017

Units Affected
121
Recall Date
September 6, 2017
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3611-2017.

While reviewing the allergen listings for our products and cross referencing against the updated spec sheet from the manufacturer of the bread base, it was discovered that the allergen statement had been updated from only wheat to wheat, milk, egg and soy.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3611-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Coborn's, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3611-2017.

Coborn's, Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Coborn's, Inc Recall FAQ

Coborn's, Inc is the subject of a bakery & grains safety report: Coborn's/Cash Wise Caraway Rye Bread - UPC 7-33147-20155-8 Net Wt. 16 oz (1.0 lb) (454 g) Sell by 9/6/2017. The notice was published on September 6, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 121 units are potentially affected.